Dongli Cao

891 total citations · 1 hit paper
18 papers, 673 citations indexed

About

Dongli Cao is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Dongli Cao has authored 18 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Dongli Cao's work include Cholesterol and Lipid Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Dongli Cao is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Dongli Cao collaborates with scholars based in China, Taiwan and Canada. Dongli Cao's co-authors include Weiya Cao, Jinhong Li, Pan Yu, Yan‐Wei Hu, Chao‐Ke Tang, Zhenyu Liao, Xiaoxu Li, Yaling Tang, Xiang Ou and Xiaoyan Dai and has published in prestigious journals such as Food Research International, International Journal of Biological Macromolecules and Atherosclerosis.

In The Last Decade

Dongli Cao

17 papers receiving 661 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An overview of autophagy: Mechanism, regulation and research progress

2021 289 citations Weiya Cao, Jinhong Li et al. Bulletin du Cancer profile →

Peers

Dongli Cao

MB

EPIDE

SURGE

PS

CR

Min Gi Japan

Qiaoling Song China

Ilijana Grigorov Serbia

Chantal Courtemanche Canada

Zihui Zhang China

Nuray Varol Türkiye

Huimin Yang China

Wenwen Wang China

Mickaël Rialland France

Masayoshi Fujisawa Japan

Min Gi Japan

Dongli Cao

381 ×1.4

MB

109 ×0.6

EPIDE

95 ×0.7

SURGE

50 ×0.4

PS

162 ×1.5

CR

Citations per year, relative to Dongli Cao Dongli Cao (= 1×) peers Min Gi

Countries citing papers authored by Dongli Cao

Since Specialization

Citations

This map shows the geographic impact of Dongli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongli Cao more than expected).

Fields of papers citing papers by Dongli Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongli Cao. The network helps show where Dongli Cao may publish in the future.

Co-authorship network of co-authors of Dongli Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Dongli Cao. A scholar is included among the top collaborators of Dongli Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongli Cao. Dongli Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Li, Weiyi, et al.. (2025). Epithelial–mesenchymal transition in pulmonary fibrosis: molecular mechanisms and emerging therapeutic strategies. Frontiers in Medicine. 12. 1658001–1658001.

2.

Liao, Zhenyu, et al.. (2024). Occurrence and exposure evaluation of 2- and 3-monochloropropanediol (MCPD) esters and glycidyl esters in refined vegetable oils marketed in Tianjin of China. Journal of Food Composition and Analysis. 130. 106150–106150. 4 indexed citations

3.

Deng, Yalan, et al.. (2024). Blood L‐cystine levels positively related to increased risk of hypertension. Journal of Clinical Hypertension. 26(12). 1411–1423. 1 indexed citations

4.

Yang, Xu, Dongli Cao, Haiyu Ji, et al.. (2023). Physicochemical characterization, rheological properties, and hypolipidemic and antioxidant activities of compound polysaccharides in Chinese herbal medicines by fractional precipitation. International Journal of Biological Macromolecules. 242(Pt 1). 124838–124838. 17 indexed citations

5.

Liao, Zhenyu, et al.. (2023). Occurrence and exposure evaluation of polycyclic aromatic hydrocarbons in tea samples consumed in Beijing-Tianjin-Hebei regions of China. Journal of Food Composition and Analysis. 123. 105606–105606. 4 indexed citations

6.

Liao, Zhenyu, et al.. (2022). Monitoring and risk assessment of perchlorate in tea samples produced in China. Food Research International. 157. 111435–111435. 14 indexed citations

7.

Yang, Xu, et al.. (2022). Optimization of Extraction of Compound Flavonoids from Chinese Herbal Medicines Based on Quantification Theory and Evaluation of Their Antioxidant Activity. Journal of Food Quality. 2022. 1–10. 2 indexed citations

8.

Cao, Weiya, et al.. (2021). An overview of autophagy: Mechanism, regulation and research progress. Bulletin du Cancer. 108(3). 304–322. 289 indexed citations breakdown →

9.

Cao, Weiya, et al.. (2021). Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development. Toxicology Mechanisms and Methods. 32(6). 395–419. 145 indexed citations

10.

Liao, Zhenyu, et al.. (2019). Occurrence of perchlorate in processed foods manufactured in China. Food Control. 107. 106813–106813. 36 indexed citations

11.

Chen, et al.. (2014). A novel co-training object tracking algorithm based on online semi-supervised boosting. 1 indexed citations

12.

Cao, Dongli, Kai Yin, Zhongcheng Mo, et al.. (2010). Lipopolysaccharide Down-regulates ABCA1 Expression in Foam Cells in a Nucleus Factor-κB Pathway-dependent Manner*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 37(5). 540–548. 1 indexed citations

13.

Cao, Dongli, Kai Yin, Zhongcheng Mo, et al.. (2010). Lipopolysaccharide Down-regulates ABCA1 Expression in Foam Cells in a Nucleus Factor-κB Pathway-dependent Manner*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 37(5). 540–548. 5 indexed citations

14.

Ou, Xiang, Xiaoyan Dai, Zhifeng Long, et al.. (2008). Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression. Science in China Series C Life Sciences. 51(5). 418–429. 15 indexed citations

15.

Dai, Xiaoyan, Xiang Ou, Dongli Cao, et al.. (2008). The Effect of T0901317 on ATP-binding Cassette Transporter A1 and Niemann-Pick Type C1 in ApoE−/− Mice. Journal of Cardiovascular Pharmacology. 51(5). 467–475. 43 indexed citations

16.

Cao, Dongli, Yan‐Wei Hu, Xiaoxu Li, et al.. (2008). IFN-γ down-regulates ABCA1 expression by inhibiting LXRα in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis. 203(2). 417–428. 71 indexed citations

17.

Dai, Xiaoyan, Xiang Ou, Dongli Cao, et al.. (2008). Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice. Acta Biochimica et Biophysica Sinica. 40(3). 261–268. 5 indexed citations

18.

Dai, Xiaoyan, Xiang Ou, Dongli Cao, et al.. (2007). Effect of T0901317 on Hepatic Proinflammatory Gene Expression in ApoE−/− Mice Fed a High-fat/high-cholesterol Diet. Inflammation. 30(3-4). 105–117. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact